Latest Breaking News On - Hermineo masitinib - Page 1 : comparemela.com

PRESS RELEASE AB SCIENCE HAS BEEN AUTHORIZED BY THE SWEDISH MEDICAL PRODUCTS AGENCY TO INITIATE CONFIRMATORY PHASE III TRIAL OF MASITINIB IN PROGRESSIVE.

United statesFrance generalArthur rouillScler frontotemporal degenerKate barretteOlivier hermineHermineo masitinibFrench medicine agencyAmericas committee for treatmentSwedish medical products agencyResearch in multiple sclerosisScientific committeeEuropean committee for treatmentPrimary progressive multiple sclerosisSecondary progressive multiple sclerosisCompare efficacy